Additionally, as adjuvant therapy for AML, she also received DAE (Ida+AraC+VP-16), improved Bu/Cy (AraC+busulfan+CTX+VM-26+MeCCNU), MTX+MD-AraC, CAG (AraC+ACR+G-CSF), and HAG (AraC+HHT+G-CSF) intravenous chemotherapy. This evidence concerns the gene CSF3 and acute myeloid leukemia.